It's time to get serious about the economics of expanded access - STAT
Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic. - ScienceDirect
Expanded Access | FDA
Industry Perspective: Expanded Access Programs - ppt download
Expanded Access — Innovation Pharmaceuticals Inc.
FDA Updates Expanded Access Program to Boost Patient Experiences
What is the Process for Expanded Access Programs? | Early Access Care
FDA Expanded Access Program: A Comprehensive Guide - BTC
Right to Try Pros and Cons
Investigational New Drugs: FDA Has Taken Steps to Improve the Expanded Access Program but Should Further Clarify How Adverse Events Data Are Used | U.S. GAO
The Basics of the Individual Expanded Access Request Process: A Resource for Physicians - WCG IRB
Individual Patient Expanded Access: Developing Principles For A Structural And Regulatory Framework | Health Affairs
Expanded Access to Unapproved Drugs or Biologics - UCI Office of Research
WideTrial
U.S. FDA on Twitter: "Have you heard of “Expanded Access?” It's a potential pathway for patients with immediately life-threatening conditions to gain access to an investigational medial product. Here's how the process
The Basics of the Individual Expanded Access Request Process: A Resource for Physicians - WCG IRB
Expanded Use of Investigational Drugs and Devices
Practical, Legal, and Ethical Issues in Expanded Access to Investigational Drugs | NEJM
Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits
Why It Is Important to Develop a Good Expanded Access Policy
Exploring the Landscape for Compassionate Use | Clinigen
Exploring the Landscape for Compassionate Use | Clinigen
Expanded Access for Unapproved Drugs and Biologics | Research
Expanded Access Part 1: Introduction - YouTube
Do Your Patients Need Access to Investigational Drugs, Biologics, or Medical Devices Through FDA's Expanded Access Pathway? — MICHR
Expanded Access vs. Right to Try: What Patients Need to Know » Triage Cancer | Finances-Work-Insurance
Expanded Access to Investigational Drugs - IRB - The University of Utah